AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER
|
|
- Irma Horton
- 6 years ago
- Views:
Transcription
1 AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER Volume 15 Issue 1 In This Issue: Meeting Filtration Requirements with the Agilent 850-DS Proposed Changes to Testing Gelatin Capsule Shells with Cross-linking Dissolution Source Book Triple Play Tips and Tricks to Improve Your Dissolution Testing Meeting Filtration Requirements with the Agilent 850-DS Dissolution testing involves two stages: sample preparation in the dissolution apparatus, and sample analysis. Filtration is an essential step to ensure the sample is representative for a given time point; the time at which a sample is withdrawn from the dissolution vessel and is immediately filtered marks when the dissolution process stops. Once cleared of solid particles and excipient material, the sample is now ready for analysis the second test stage. The analysis of filtered samples is generally performed by UV-Vis spectrophotometry or HPLC; the analytical method may impact the type of filtration required to ensure sample integrity. For instance, sub-micron filtration may be needed to reduce potential blockage of HPLC column inlets caused by particulates and excipient matter from sample solutions, to extend column life. Whether a dissolution method is performed manually or automatically, filters must be challenged for efficiency, adsorption, and leachability. If excessive absorption of the active drug occurs, excipient interference is high, or filters become clogged, alternative filters may be required. Filtration Capability of the 850-DS The 850-DS Dissolution Sampling Station can be used with cannula tip filters and/or an optional automated filter changer that can greatly improve the processing of dissolution samples through the use of innovatively designed filter plates. Changing the filters between time points lessens the risk of the filter becoming clogged and helps eliminate erroneous results from particles trapped on the filter from the previous time point. The system utilizes filter plates that are consistent with filtration membranes and housing materials currently used for dissolution sampling, made by GE Whatman specifically for use with the Agilent 850-DS. The only differences between traditional luer-type syringe filters and the filter plates are the absence of the luer fittings and the inclusion of eight disks on a flat cartridge. The compact arrangement of the filter disks on the filter plate continued on p. 2
2 Meeting Filtration Requirements with the Agilent 850-DS... continued also makes it much easier for automated equipment to process and filter samples, as compared to traditional automationready filters. For most purposes, the filter plate would require minimum validation for methods requiring the identical filter membrane when a method has been validated for a specific filter membrane or equivalent. Otherwise, filter revalidation may be performed with the abbreviated filter validation protocol for efficiency and adsorption. To ensure the integrity of the sample filtrate, it is necessary to demonstrate that the performance of the GE Whatman filter plate is equivalent to that of the filter currently in use, and that the required volume to saturate the filter with active drug is the same. For optimal performance, Agilent Full Flow pre-filters should be in place on the sampling cannulas to prevent larger particles from entering the sampling system. If particles of undissolved active Agilent Full Flow Filters drug are allowed to enter the sampling lines and flow path, dissolution results may be inadvertently increased due to further dissolution of active drug particles through shear forces and turbulence within the sampling system. Use of a Full Flow pre-filter can also prevent clogging of the finer pore size filters, and may even allow for multiple uses of the same filter plate. Another way that the sample integrity can be maintained is by verifying adsorbance of the active drug on the filter, and determining the amount of sample that must be passed through filters to keep active drug from binding to the filter materials. Agilent has provided a thorough filter validation template for the 850-DS that may be helpful in the development of new dissolution methods, in method transfer, and in exploring the use of alternative filters. Download the Agilent Filter Validation Protocol at chem/ en Learn More If you have questions regarding this protocol, feel free to contact the Dissolution Hotline at dissolution. hotline@agilent.com. Agilent 850-DS with Optional Filter Changer and Filter Plates Proposed Changes to Testing Gelatin Capsule Shells with Cross-linking 2 Problems associated with cross-linking in gelatin capsules have been prevalent enough that a USP Workshop on Dissolution Testing of Capsules was conducted to discuss improvements to USP Chapters <711> and <2040> in order to find optimum ways to address the issue. Cross-linking of capsule shells has been one of the most challenging aspects of dissolution testing in recent years. Cross-linking is the formation of new bonds between gelatin and itself, aldehydes, free radicals, etc., especially in the presence of light, heat, and humidity. When this occurs, the capsule shell becomes resistant to opening and can slow or prevent the active drug from dissolving. Most commonly, this change is visible, as you will see pellicle formation on the capsule shell, which may resemble balloons, tentacles, or other formations. continued on p. 3
3 Proposed Changes to Testing Gelatin Capsule Shells with Cross-linking... continued Dissolution testing of these cross-linked products often leads to failure due to the restricted openings. As a result, USP Chapters <711> and <2040> historically have allowed the use of biological enzymes found in the stomach and intestinal region for dissolution testing pepsin in acidic ph and pancreatin in neutral ph media. These enzymes could be added when cross-linking was visually apparent or a dissolution test failed due to suspected cross-linking. The use of pepsin and pancreatin was partially successful in addressing failure due to cross-linking; however, neither enzyme is well suited for ph between An in-process revision of <711> is currently viewable in USP Pharmacopeial Forum 40(6). The revision contains modifications for enzyme use for capsule shells, with two additional enzymes specified for use in intermediate ph, and an increase in the amount of pancreatin for neutral ph. Other revisions include pre-treatment of a product in enzymes when the enzymes are not compatible with surfactants or other ingredients in the media. The deadline for public comment on revisions to <711> was January 31st, Dissolution Enzyme Selection Enzymes can be utilized when the dosage form fails to meet the acceptance-table criteria for a product. In such cases, dissolution would be repeated with the addition of enzymes to the dissolution media, either during the test or as part of a pre-soaking procedure. It is not required to fail through all three stages as long as evidence of cross-linking is observed as described in USP <1094>: Capsules Dissolution and Related Quality Attributes. Enzyme selection is dependent on the ph of the media being tested. For media ph 4.0, pepsin can be used in the amount of 750,000 units/l of dissolution media. For media ph > 4.0 and < 6.8, the enzymes papain or bromelain can be used at 550,000 units/l or NMT 30 gelatin-digesting units (GDU)/L of dissolution media, respectively. For media ph 6.8, pancreatin can be used at 2000 units/l, an increase from the previous limit of 1750 units/l. The determination of activity for each of the enzymes can be found in the Reagent Specifications section of the USP under each of their names. Cross-linking should be studied during dissolution method development for encapsulated products to determine the type and amount of enzyme that should be used. Forced cross-linking studies may be conducted by exposing the dosage form to high humidity or by spiking with formaldehyde or other cross-linking agents. Pre-soaking with Enzymes Enzymes have been known to become denatured or exhibit altered activity in the presence of surfactants and other ingredients. In these cases, the sample can be pre-soaked in the dissolution media without the presence of the surfactant. The pre-treatment time is counted as part of the total time of the dissolution run, and can occur either in the dissolution vessel or in another location, such as a beaker. The time of the pre-treatment is recommended not to exceed 15 minutes. The pre-soak can occur in a small volume of solution, which is then added to the rest of the dissolution media at the end of the soaking period; however, the total volume must be equal to the total volume required in the dissolution method. The pre-soak procedure, volume, mixing conditions, etc. should be determined as part of method development for each product. Prevention of Cross-linking Cross-linking is problematic in in vivo dissolution testing as well as in vitro. The most important thing in dealing with gelatin capsule shells is prevention through good formulation and packaging design. Using high-quality gelatin and choosing excipients less prone to forming aldehydes will reduce the occurrence of cross-linking. Packaging that protects the capsules from humidity and light can also slow the formation of cross-linking. Summary The addition of papain and bromelain as options for addressing cross-linking, as well as the increased allowable amount of pancreatin, should help address many of the challenges encountered with the previous USP procedure. As always, methods should be validated for use with and without enzymes when working with gelatin capsule shells in order to assure accurate and reliable dissolution testing. References USP Workshop on Dissolution Testing of Capsules, March 24-25, 2014, Rockville, MD. US Pharmacopeia <711> Dissolution, Pharmacopeial Forum 40(6), Nov-Dec, 2014 US Pharmacopeia <1094> Capsules-Dissolution Testing and Related Quality Attributes, Pharmacopeial Forum 40(6), Nov-Dec, 2014 US Pharmacopeia <2040> Disintegration and Dissolution of Dietary Supplements, Pharmacopeial Forum 40(6), Nov-Dec, 2014 US Pharmacopeia, Stimuli to the Revision Process: Use of Enzymes in the Dissolution Testing of Gelatin Capsules and Gelatin-Coated Tablets Revisions, Pharmacopeial Forum 40(6), Nov-Dec, 2014 US Pharmacopiea, Stimuli to the Revision Process: Collaborative Development of Two-Tier Dissolution Testing for Gelatin Capsules and Gelatin- Coated Tablets Using Enzyme-Containing Media, Pharmacopieal Forum 24(5), Sept.-Oct
4 Dissolution Source Book Triple Play For the first time, the Dissolution Systems Source Book has been released in three different formats: printed catalog, PDF, and now for an interactive version we are excited to call our Digital Source Book. While the PDF version is identical to our printed catalog, the Digital Source Book offers a wide variety of enhancements and features: Simple navigation, including a hyperlinked Table of Contents with thumbnails Digital Source Book Cover Embedded product videos and demonstrations Hyperlinks to brochures and white papers Product-specific ordering information Simplified Navigation Our Digital Source Book represents a more streamlined alternative to our printed and PDF catalogs. Over 190 pages have been condensed into 49 slides of interactive content, with an emphasis on delivering the information you need about our products in a more accessible way. Our new Contents page includes convenient thumbnails so you can navigate to any instrument or service visually. We have also included an easy-to-use search box that can be accessed on every page. Content is organized into digital chapters, allowing you to quickly advance through sections, based on your interest. Digital Source Book Table of Contents 4 Embedded Videos Want to see how a particular instrument or hardware/software feature works? Need to know how to validate filters or convert one of our dissolution apparatus for small-volume dissolution? Want to a watch a quick overview of the Dissolution Discussion Group, dissoguard, or Seminar Series, etc.? continued on p. 5 Digital Source Book Videos
5 Dissolution Source Book Triple Play... continued One way to see our instruments in action is to schedule a live Labcast HD demo with our team of dissolution experts (using the Contact Us link included on every slide of the Digital Source Book). Another way is to use the new embedded-video links in the Digital Source Book. Videos include segments on everything from individual features to full-length tutorials and demonstrations. Brochures and White Papers A variety of product brochures and white papers for our dissolution products can now be accessed directly from the slides of our Electronic Source Book. These resources expand on the content in the Electronic Source Book, providing much greater detail than is available in the printed catalog. Digital Source Book Literature Ordering Information While the page count has been reduced for the Electronic Source Book, ordering information has not been sacrificed. Context-sensitive ordering information is available on throughout the Digital Source Book that will take you directly to the pages in the PDF Source Book applicable to the content you are viewing. We hope you find this new way of interacting with our Source Book both useful and enjoyable. It is available today for viewing on your computer or any mobile device that supports Adobe Flash. Digital Source Book Ordering Information To get your copy, visit com/chem/dissolution-sourcebook or contact us at dissolution. hotline@agilent.com. 5
6 Tips and Tricks to Improve Your Dissolution Testing the medium is not necessary, correct for the volume change in the calculation. This means that an equivalence study one with media replacement and one without can be performed to demonstrate that dissolution results are not affected. In this case, we also need to ensure that the sink conditions remain satisfied as media is withdrawn throughout the experiment, and sufficient volume remains for adequate agitation. Media Replacement vs. Mathematical Calculations USP <711> states where multiple sampling times are specified, replace the aliquots withdrawn for analysis with equal volumes of fresh dissolution media at 37 C. This statement appears to require replacement of media for all multiple-sample time point methods. And, while most dissolution manufacturers offer this feature as standard (as with Agilent s 850-DS Sampling Station) or as an option, it is important to understand if it is really necessary is it the most accurate way to account for the vessel volume lost due to sampling? Sink Conditions Having a volume of medium at least three times the volume required to form a saturated solution of drug substance. In fact, the full text of <711> directs to replace the aliquots withdrawn for analysis with equal volumes of fresh dissolution media at 37 C or, where it can be shown that replacement of Performing such a study and demonstrating that a) sink conditions are maintained, b) adequate volume remains for agitation, and c) results are not affected, not only eliminates an additional step in the process but also removes a potential source of error. Mathematically, it is necessary to account for sample removed and, when necessary, replaced in % and mg dissolved calculations. However, when fresh media is added back to the dissolution vessel either manually or automatically volume accuracy is at risk. Minimizing volume removal and addition lessens the chances of inaccuracies or compounded errors. By simply adjusting the formula to fit your method you can save time, reduce steps, and improve overall dissolution test accuracy. Dissolution Sample Dilution: Physical vs. Optical Dissolution samples can occasionally present certain analytical challenges. These may arise from any number of sources, and may force exploration of sample dilution to improve analysis. Often, the first inclination is simply to dilute samples with fresh dissolution medium, which can be accomplished manually or automatically depending on the pumps and instrumentation available. However, in many cases this is not the most efficient or accurate way to achieve high-quality results. Manual sample dilution adds time to the overall dissolution process and introduces potential error related to contamination or inaccuracy. While automated dilution does save time, it can lead to volume inaccuracies caused by the inherent specifications of pumps used as part of this process. To meet the requirements of small volume sample dilution, each of these factors should be considered. continued on p. 7 6
7 Tips and Tricks to Improve Your Dissolution Testing.. continued One alternative method to achieve the necessary sample dilution one that does not require any modification to the sample itself is to optically dilute. This practice is most effective in an automated or online UV-Vis dissolution system where a variety of flow cells are available for sample analysis. By simply changing the path length of the flow cell and maximizing the linear range of the spectrophotometer, it is possible to increase the absorbance of the sample by however much is needed. This allows for analysis of a wide range of sample concentrations. Implementation of this approach saves sample preparation time by removing the physical dilution step. It also eliminates any chance of volume inaccuracies and helps ensure the integrity of the sample. Agilent s Dissolution Workstation Software Dissolution Workstation software provides control of up to four manual or semi-automated dissolution systems from a single workstation. Ideal for laboratories adhering to 21-CFR- Part-11 requirements, this easy-to-use software: Consolidates and maintains all your dissolution data in a secure, centralized database Agilent s Cary 60 boasts a linear range of up to 4 Abs and can utilize flow cells ranging from 0.2 to 10 mm in an online UV dissolution system. FREE for a Limited Time Discover Your Paperless, Compliant Lab Solution All Agilent dissolution orders containing any of the following instrumentation will now receive a complimentary copy of the latest Dissolution Workstation software: 708-DS or 709-DS Dissolution Apparatus Bio-Dis Reciprocating Cylinder (USP Apparatus 3) Reciprocating Holder (USP Apparatus 7) 850-DS Sampling Station Complies with the latest enhanced mechanical qualification (MQ) guidelines Integrates the new 850-DS and its automated cleaning cycle for long-lasting performance Accelerates failure investigations by monitoring the dissolution apparatus for vibration using the Instrument Module (IM) of the 280-DS MQS This offer won t last long, so take advantage of this excellent value and see how easy it can be to manage your dissolution methods and systems with one convenient, compliant solution. Contact your Agilent representative today for more details! Learn More Contact us at dissolution.hotline@agilent.com. 7
8 Learn more The information is subject to change without notice. Agilent Technologies, Inc Printed in the USA, February 1, EN
Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology
Technical Overview Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology Introduction Online fiber-optic and multicell UV-dissolution systems have become increasingly
More informationAGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER VOLUME 16 ISSUE 4 PAGE 1 The 280-DS Mechanical Qualification System Not Just an Agilent Thing PAGE 3 You Asked, We Listened: New Inline Filtration for
More informationTHE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION
THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION Pharmacopeial Forum Vol. 31(5)(Sept.-Oct. 2005) By : Mr. Seubpong Kumpusiri Mrs. Patima Maneesatid 26 May 2006 THE DISSOLUTION PROCEDURE: DEVELOPMENT
More informationAGILENT VACUUM-FORMED (VF) MOLDED DISSOLUTION VESSELS
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER VOLUME 15 ISSUE 3 PAGE 1 Agilent Vacuum-Formed (VF) Molded Dissolution Vessels PAGE 5 Learn. Solve. Discuss. PAGE 6 Gelatin Cross-linking and Dissolution
More informationAGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER Volume 12, Issue 2 In This Issue: Enhanced Mechanical Qualification 1 Dissolution Qualification Timeline / Schedule 3 MQ Survey 4 MQ Guidance Summary
More informationTroubleshooting Differences Between Labs. Ken Boda Dissolution Applications Engineer
Troubleshooting Differences Between Labs Ken Boda Dissolution Applications Engineer Agenda Dissolution Run Failure Investigation Differences in data between sites Potential causes of site to site differences
More informationCE 7smart Flow-Through Dissolution System
CE 7smart Flow-Through Dissolution System In-vitro drug release testing in compliance with USP apparatus 4, EP, and JP Configurations for various methods and analytical requirements Specific flow-through
More informationDISSOLUTION TESTING OF GELS, TOPICAL CREAMS & OINTMENTS
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER VOLUME 15 ISSUE 4 PAGE 1 Dissolution Testing of Gels, Topical Creams & Ointments PAGE 4 Dispelling a Myth: 6- versus 12-Position Dissolution Units PAGE
More informationDeveloping and Validating Dissolution Procedures for Improved Product Quality
W H I T E P A P E R Developing and Validating Dissolution Procedures for Improved Product Quality By Michael Swartz, Ph. D., Director of Research and Development, and Mark Emanuele, Chemist Abstract In
More informationAgilent LC Dissolution Software STREAMLINE LC DISSOLUTION ANALYSIS
Agilent LC Dissolution Software STREAMLINE LC DISSOLUTION ANALYSIS AGILENT LC DISSOLUTION SOFTWARE STREAMLINE LC DISSOLUTION ANALYSIS AND IMPROVE YOUR LABORATORY WORKFLOW A small link in the chain is often
More informationIJPRD, 2013; Vol 5(02): April-2013 ( ) International Standard Serial Number
IJPRD, 2013; Vol 5(02): April-2013 (106 112) International Standard Serial Number 0974 9446 --------------------------------------------------------------------------------------------------------------------------------------------------
More informationPerformance Testing of Novel Dosage Forms
RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies
More informationTake Control of Your Workflow. Agilent Dissolution Workstation Software
Take Control of Your Workflow Agilent Dissolution Workstation Software 2 You Have Questions...We Can Help You Find Answers How much time could we save and how many transcription errors could we avoid if
More information"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY
"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo
More informationSpectroscopy Solutions for Pharmaceuticals:
Spectroscopy Solutions for Pharmaceuticals: Confidence in Compliance to USP Using the Agilent Cary 60 UV-Vis Spectrophotometer White Paper Introduction UV-Vis spectroscopy is one of the most commonly
More informationAT 70smart Fully Automated Dissolution System
AT 70smart Fully Automated Dissolution System Fully automated from media preparation to data reporting Batch up to 40 lots of Apparatus 1 or 2 methods including the use of sinkers Powerful DoE screening
More informationAgilent Dissolution Workstation Software PERFECTING WORKFLOW DYNAMICS
Agilent Dissolution Workstation Software PERFECTING WORKFLOW DYNAMICS AGILENT DISSOLUTION WORKSTATION SOFTWARE TAKE CONTROL OF YOUR WORKFLOW You have questions How much time could you save and how many
More information400-DS Dissolution Apparatus 7
400-DS Dissolution Apparatus 7 Unsurpassed Commitment to Innovation The 400-DS Dissolution Apparatus 7 is the result of Agilent s strong commitment to innovation in the areas of automation and integration
More informationGOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System
GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System Introduction The objective of good laboratory practice (GLP) is to obtain accurate and precise results, using a measurement system
More informationQUALITY OF PROLONGED RELEASE ORAL SOLID DOSAGE FORMS
QUALITY OF PROLONGED RELEASE ORAL SOLID DOSAGE FORMS Guideline Title Quality of Prolonged Release Oral Solid Dosage Forms Legislative basis Directive 75/318/EEC as amended Date of first adoption October
More informationAGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER Volume 13 Issue 2 In This Issue: Work Smarter, Not Harder: Agilent s Online UV Dissolution Systems Sampling Made Simple: 850-DS Dissolution Sampling
More informationTransferring Dissolution Methods. Kenneth Boda Applications Engineer
Transferring Dissolution Methods Kenneth Boda Applications Engineer Agenda Prerequisites of a Method Transfer Transferring a Method to Automation Transferring a Method to Another Lab Determining Appropriate
More informationApplication of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal Systems
dx.doi.org/10.14227/dt140207p25 Application of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal Systems Marilyn X. Zhou 1, Duane Shoudt, Genaro Calderon, and Min Feng Analytical Research
More informationDissolution Market. Vinod Mehta
Dissolution Market Vinod Mehta Objective Dissolution - What is it? Market and Product Situation Carl Zeiss Offering System Packages Competition What is Dissolution Solid dosage form assays in the pharmaceutical
More informationá1225ñ VALIDATION OF COMPENDIAL PROCEDURES
1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst
More informationUSP s Perspective on Drug Product Performance Test
USP s Perspective on Drug Product Performance Test Course Overview 1. The concept of in vitro dissolution Definition and application 2. Compendial dissolution/ drug release testing 3. Method development
More informationASSESSING THE DRUG RELEASE FROM NANOFORMULATIONS WHEN, WHY AND HOW?
ASSESSING THE DRUG RELEASE FROM NANOFORMULATIONS WHEN, WHY AND HOW? Matthias G. Wacker, PhD matthias.wacker@ime.fraunhofer.de Pharma Test Workshop Series 2016 NANOTECHNOLOGY IN THE PHARMACEUTICAL INDUSTRY
More informationBIOPHARMACEUTICS CLASSIFICATION SYSTEM-BASED BIOWAIVERS - M9
BIOPHARMACEUTICS CLASSIFICATION - M9 Step 2 document to be released for comments Date 7 June 2018 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 Legal
More informationWho we are? Dissolution testing of modified release forms. Dissolution testing of immediate/ modified release forms
Dissolution testing of modified release forms Mumbai - 2013, May 3 Samir Haddouchi samir.haddouchi@sps-pharma.com 1 Dissolution testing of immediate/ modified release forms Mumbai - 2013, May 3 Samir Haddouchi
More informationmdi Filters for Sample Preparation
mdi Filters for Sample Preparation Sample filtration is a very important part of any analytical procedure as it is required to safegaurd certified microfilters for filtration of organic solvents, chemicals,
More informationAgilent TRS100 Raman. Quantitative Pharmaceutical Analysis System
Agilent TRS100 Raman Quantitative Pharmaceutical Analysis System Agilent TRS100 Raman Streamlined Quality Control Fast Test hundreds of intact tablets or capsules in minutes Simple Quantify active pharmaceutical
More informationFUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP <621> GUIDELINES
FUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP GUIDELINES How to use UPLC technology within allowable adjustments to improve QC laboratory throughput For many in the
More informationImage Area YOUR PRESCRIPTION FOR USP 232/233 COMPLIANCE. USP 232 / 233 Readiness Solutions and Services Overview
Image Area YOUR PRESCRIPTION FOR USP 232/233 COMPLIANCE USP 232 / 233 Readiness Solutions and Services Overview THE RIGHT DOSE OF READINESS AT JUST THE RIGHT TIME When the U.S. Pharmacopeia s (USP) new
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL DISSOLUTION This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control
More informationA Simple and Economical Approach/Concept to Evaluate Quality of Pharmaceutical Products Based on an Improved Dissolution Testing Methodology
The Open Drug Delivery Journal, 2008, 2, 33-37 33 Open Access A Simple and Economical Approach/Concept to Evaluate Quality of Pharmaceutical Products Based on an Improved Dissolution Testing Methodology
More informationSample Quantitation. Spectrophotometry 18. Protein Assays 20. Ordering Information 23
Sample Quantitation Spectrophotometry 18 Protein Assays 20 Ordering Information 23 Spectrophotometry www.bio-rad.com/spectrophotometry Spectrophotometry SmartSpec Plus Spectrophotometer Order Info: Pg
More informationOur design fits everywhere
Fully Automated System with Basket Station BS 60 Our design fits everywhere ISO 9001 Up to 15 unattended paddle dissolution tests (USP Apparatus 2) with the AT 70smart Paddle Station Up to 10 unattended
More informationSample Quantitation. Protein Assay Kits 20. Spectrophotometry 23 Cuvettes 25
Sample Quantitation Protein Assay Kits 20 Spectrophotometry 23 Cuvettes 25 Protein Assay Kits bio-rad.com/proteinassays Protein Assay Kits See Also SmartSpec Plus spectro photometer: page 23. Microplate
More informationElemental impurities impact on APIs
Regulatory Expectations on impurities in Drug Substances: Authority and Industry perspective Pavia, 2nd October 2015 Elemental impurities impact on APIs October 2 nd 2015 Annalisa Scali RegulatoryAffairsManager
More informationปฏ มา มณ สถ ตย เภส ชกรช านาญการพ เศษ. Scope. Dissolution Overview <1094>
ปฏ มา มณ สถ ตย เภส ชกรช านาญการพ เศษ Scope Dissolution Overview Scope, General chapter Dissolution Drug Release Capsules-Dissolution Testing and Related Quality Attributes
More informationAgilent 8453 Spectrophotometer and UV-visible ChemStation for Dissolution Testing. Solution Bundles for automated Dissolution Testing
Agilent 8453 Spectrophotometer and UV-visible ChemStation for Dissolution Testing Solution Bundles for automated Dissolution Testing General considerations UV benefits Simple, rugged and reliable equipment
More informationDissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances
Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances Guidance for Industry U.S. Department of Health and Human
More informationPHARMACEUTICAL SCIENCES - QUESTIONS AND ANSWERS
PHARMACEUTICAL SCIENCES - QUESTIONS AND ANSWERS The document PHARMACEUTICAL SCIENCES - QUESTIONS AND ANSWERS is intended to provide clarification on a number of issues that relate to Quality (e.g., Chemistry
More informationTEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)
APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation
More informationInternational Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW
International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW SUKHDEV SINGH *1 AND JASBIR SINGH 2 1 Rayat Institute
More informationVersion 3 Application Notes
Integrated Solutions Version 3 Application Notes Tablet Dissolution, Content Uniformity and Sample Preparation Automation unique automated analytical solutions for both UV and HPLC Analysis The IDISis
More informationPHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS
PHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS J. T. Carstensen, Ph.D. Professor of Pharmacy University of Wisconsin Madison, Wisconsin TECHNOMIC ^PUBLISHING CO.. INC J 1.ANCASTER BASET, TABLE OF CONTENTS
More informationEnsure high performance chromatography by using particle free mobile phases and sample solutions
Ensure high performance chromatography by using particle free mobile phases and sample solutions Protect your columns, Particles from your samples and mobile phase can contaminate your system and/or block
More information29-Apr Outline. Automation in dissolution testing. Mumbai , May 4 Samir Haddouchi
Automation in dissolution testing Mumbai - 2013, May 4 Samir Haddouchi samir.haddouchi@sps-pharma.com 1 Outline - Introduction about automation - Automation for dissolution testing - Validation of automated
More informationWater Analysis. NANOCOLOR Automatic turbidity check for tube tests. Maximum result safety MACHEREY-NAGEL.
Water Analysis NANOCOLOR Automatic turbidity check for tube tests Maximum result safety MACHEREY-NAGEL Automatic turbidity check Turbidity a source of error in photometry As a source of error in photometry,
More informationAnalytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP
Analytical Method Transfer Program Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Outline Requirements for an AMT Program Develop Your AMT Program Qualify Your AMT Program On-going
More informationUpdate to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014
Update to USP Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014 2015 Waters Corporation 1 What is the USP-NF? The United States Pharmacopeia National Formulary (USP-NF)
More informationThank You to United States Pharmacopeia for Their Sponsorship and Assistance
Use of Measurement Uncertainty in Testing a Drug Substance M.L. Jane Weitzel Quality Analysis Consultants mljweitzel@msn.com Eurachem/CITAC Workshop June 2011 Thank You to United States Pharmacopeia for
More informationBetter wet granulation: development, scale-up and manufacture
Better wet granulation: development, scale-up and manufacture By Tim Freeman, Freeman Technology Wet granulation is a common unit operation in the pharmaceutical industry yet accurate endpoint detection
More informationFILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS
FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer
More informationPerspectives on Method Validation: Importance of Adequate Method Validation
Perspectives on Method Validation: Importance of Adequate Method Validation Heather Bridwell, Vikas Dhingra, Daniel Peckman, Jennifer Roark and Thomas Lehman The appropriate validation of analytical methods
More informationMicrocrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate
Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate Ready-to-Use High Functionality Excipient Composite Offering Advantages for Total Cost Savings Superior
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer
More informationLANGE LABORATORY AUTOMATION >>GANIMEDE SERIAL DIGESTION. The serial analysis system for total P and N (TN b ) with integrated digestion.
LANGE LABORATORY AUTOMATION >>GANIMEDE SERIAL DIGESTION The serial analysis system for total P and N (TN b ) with integrated digestion. ANALYSIS AND DIGESTION UNIT N P + GANIMEDE Control unit with infrared
More informationDr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur
Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur GMP ( Adopted in 1975 ) In India Good manufacturing practices are the practices required in order to conform to guidelines recommended
More informationAPPLICATION NOTE. Application Note. Summary/Abstract:
APPLICATION NOTE Characterization of Gold Nanoparticle Detection Using Slope Spectroscopy (SoloVPE Variable Pathlength UV) Application Note The SoloVPE and Slope Spectroscopy offer a new method of Slope
More informationWHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED?
WHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED? GREAT SCIENCE IS BUILT ON LABORATORY-WIDE COMPLIANCE Navigating the complexities of global regulatory entities and requirements can be difficult, and the penalties
More informationAmazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING
Amazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING FILTRATION SOLUTIONS FOR PHARMACEUTICAL MANUFACTURING Delivering quality filtration products As one of Europe s leading manufacturers of process
More informationSCIEX OS Software One Touch Productivity
SCIEX OS Software One Touch Productivity Accuracy, Simplicity and Efficiency What SCIEX OS Software is all About Mass spectrometry and the data challenge Mass spectrometry continues to provide more comprehensive
More informationWhy Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services
Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and
More informationUV/Vis Spectrophotometry. Time for New Demands SPECORD PLUS
UV/Vis Spectrophotometry Time for New Demands SPECORD PLUS 2 SPECORD PLUS Series Among more than 150,000 Jena photometers installed worldwide, the SPECORD is a classic. The series of the SPECORD PLUS double-beam
More informationAgilent solutions for contract research and manufacturing organizations
Agilent solutions for contract research and manufacturing organizations Cooperation between pharmaceutical companies and contract research organizations A successful approach to increasing efficiency along
More informationGUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION
ON ANALYTICAL METHOD VALIDATION HSA September 2004 Reproduction prohibited for commercial purposes. Reproduction for internal use is authorised, provided the source is acknowledged. MQA Dir: DISK1\GUIDE-MQA-012A-004.doc
More informationAgilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS
Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS AGILENT SOLUTIONS USP / & ICH Q3D Implementing Elemental Impurities Tests in the Pharmaceutical
More informationGE Healthcare. HPLC sample preparation a study using Whatman brand filtration devices
GE Healthcare HPLC sample preparation a study using Whatman brand filtration devices HPLC sample preparation a study using Whatman brand filtration devices Sample preparation methods for HPLC analysis
More informationOral Dosage Formulation Development
Oral Dosage Formulation Development Achieving faster formulation of solid oral dosage forms for FIH supplies Dr. Colin Lorimer - published April 29, 2011 The pharmaceutical industry is increasingly looking
More informationNIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production
NIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production Slash release times with NIR Innovative features Fully automatic assay of tablet weight, hardness,
More informationAn Overview of IQ s Position Paper: Early Development GMPs for Small-Molecule Specifications
An Overview of IQ s Position Paper: Early Development GMPs for Small-Molecule Specifications On behalf of Specifications Team Kirby Wong-Moon, Ph.D. Amgen Inc. Best Practices and Application of GMPs for
More informationRegulatory Requirements of Dissolution for Generic Drug Products
Regulatory Requirements of Dissolution for Generic Drug Products Om Anand, Ph.D. Division of Biopharmaceutics, Office of New Drug Products, Office of Pharmaceutical Quality - CDER, US-FDA International
More informationUnited State Pharmacopeia: Compendial Plastic Standards: Beyond Packaging
United State Pharmacopeia: Compendial Plastic Standards: Beyond Packaging Desmond G. Hunt, Ph.D. Principle Scientific Liaison November 15, 2016 Denver, CO USP Scientific, independent, volunteer-driven,
More informationEstablished Conditions: Reportable CMC Changes for Approved Drug and Biologic Products Guidance for Industry
Established Conditions: Reportable CMC Changes for Approved Drug and Biologic Products Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments
More informationGuidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 Center
More informationGravimetric Analysis: Determination of % Sulfur in Fertilizer
Gravimetric Analysis: Determination % Sulfur in Fertilizer This is another "real world" sample experiment in this case we will analyze a fertilizer sample for the sulfate content and express the result
More informationYour Goal is Zero Positives. So is Ours.
Data Sheet Your Goal is Zero Positives. So is Ours. Granulated and Ready-to-Use Culture Media for Secure Media Fill Trials When performing media fill trials, you shouldn t have to worry about culture media
More informationGuidance for Industry
Guidance for Industry ANDAs: Blend Uniformity Analysis DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should
More informationUsing the Sartobind pico
Using the Sartobind pico Optimizing Steps for using micro-scale membrane adsorbers on liquid chromatography systems Application Note Steps for the successful use of Sartobind pico 1. Start with a new unused
More informationHow to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER
How to Avoid Common Deficiencies in INDs and NDAs Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER 1 Structure of FDA Office of Commissioner Chief Scientist FOODS Medical Products & Tobacco
More informationThermo Scientific GENESYS 10S Bio spectrophotometer
PRODUCT SPECIFICATIONS GENESYS 10S Bio UV-Visible Spectrophotometer Thermo Scientific GENESYS 10S Bio spectrophotometer Accurate and convenient life science UV-Visible measurements Designed for performance
More informationJust Prove it. Spectroquant Prove
Just Prove it. Spectroquant Prove Simplify water analysis with a new class of spectrophotometers AQA Prime Live ID Created by Merck Millipore >180 test kits & methods 100 600 300 Simplicity Durability
More informationThermo Scientific Insight 2 Software for Evolution 200 Series UV-Vis Spectrophotometers. Comprehensive solutions Simplified workflows
Thermo Scientific Insight 2 Software for Evolution 200 Series UV-Vis Spectrophotometers Comprehensive solutions Simplified workflows Accelerate your analysis No matter how you use your UV-Visible spectrophotometer,
More informationBRIEFING. . Over time, 466 may be used less frequently and may be withdrawn.
Page 1 of 13 BRIEFING 1086 USP 37 page 828. As part of an ongoing monograph modernization initiative, the United States Pharmacopeial Convention (USP) is updating this general chapter, 1086 Impurities
More informationAgilent University Course Catalog Edition Singapore
Agilent University Course Catalog 2018 Edition Singapore The value of lifetime learning Investments in continuous education improve laboratory staff productivity by uplifting knowledge and skills necessary
More informationAgilent SD-1 Purification System. Purify your way SD-1
Agilent SD-1 Purification System Purify your way SD-1 AGILENT SD-1 PURIFICATION SYSTEM PURIFY YOUR WAY WITH HIGH QUALITY SEPARATIONS AT ANY SCALE The Agilent SD-1 Purification System achieves better gradient
More informationGyrolab software modules
Gyrolab software modules Product Information Sheet D0016374/F Gyrolab Viewer Review binding profiles for individual data points at your desktop Gyrolab ADA Software Monitor anti-drug antibodies use together
More informationAgilent University Course Catalog Edition Singapore
Agilent University Catalog 2019 Edition Singapore Agilent University At Agilent University, you can find a wide range of learning options to meet the needs of your lab, optimizing productivity on your
More informationUSP 4 Flow-Through Dissolution Systems
MR and ER Tablets Medical Devices, Drug-Eluting Stents and Implants API s and Granules Suppositories and Soft Gelatine Capsules Microspheres, Microcapsules, Hydrogels and Liposomes Capsules and Pellets
More informationQuality of raw materials and manufacturing of advanced therapies. Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018
Quality of raw materials and manufacturing of advanced therapies Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018 Evolution of the compendia 1820: a single recipe book 2018: Procedures and acceptance
More informationSterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM
Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory
More informationRegulatory Assessment
Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal
More informationEnvironmental Water Testing: Surface Water, Groundwater, Hard Water, Wastewater, & Seawater
Document: AND Sol Env 08 2013 Environmental Water Testing: Surface Water, Groundwater, Hard Water, Wastewater, & Seawater Matrix specific sample preparation and testing methods for environmental waters
More informationBalancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL
Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels
More informationApplying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego
1 Applying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego Destin A. LeBlanc Cleaning Validation Technologies 2014 Destin A. LeBlanc Focus
More informationCell Therapy and Right First Time Manufacturing
Cell Therapy and Right First Time Manufacturing How a Syncade MES solution reduces process risk Right Every First Time Manufacturing In cell therapy manufacturing, each batch must be perfect the first
More informationINCREASING YOUR LABORATORY PRODUCTIVITY
Networked Agilent OpenLAB Chromatography Data Systems (CDS), Reporting and Data Management Solutions: INCREASING YOUR LABORATORY PRODUCTIVITY Whitepaper Introduction Today s laboratories seek to increase
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More information